Works in Cancer Chemotherapy & Pharmacology, 2015, Vol 75, Issue 2

Results: 24

A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA)
Published in:
2015
By:
- Kang, Yoon-Koo;
- Ryoo, Baek-Yeol;
- Yoon, Shinkyo;
- Shen, Lin;
- Lee, Jooyun;
- Wei, Chenlu;
- Zhou, Yu;
- Ryu, Min-Hee
Publication type:
Journal Article
Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 255, doi. 10.1007/s00280-014-2622-6
By:
- Wang, Ying;
- Liu, Ping;
- Xu, Yan;
- Zhang, Weihao;
- Tong, Lina;
- Guo, Zhi;
- Ni, Hong
Publication type:
Article
Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague-Dawley rats.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 263, doi. 10.1007/s00280-014-2629-z
By:
- Periyasamy, Kuppusamy;
- Baskaran, Kuppusamy;
- Ilakkia, Aruldass;
- Vanitha, Kalappan;
- Selvaraj, Sundaramoorthy;
- Sakthisekaran, Dhanapal
Publication type:
Article
Pre-treatment serum total bilirubin level as an indicator of optimal CPT-11 dosage.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 273, doi. 10.1007/s00280-014-2633-3
By:
- Makihara, Katsuya;
- Azuma, Sayaka;
- Kawato, Nobuyuki;
- Ueno, Hiroyuki;
- Nakata, Izumi
Publication type:
Article
Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 235, doi. 10.1007/s00280-014-2635-1
By:
- Ivanova, Lāsma;
- Zandberga, Elīna;
- Siliņa, Karīna;
- Kalniņa, Zane;
- Ābols, Artūrs;
- Endzeliņš, Edgars;
- Vendina, Ineta;
- Romanchikova, Nadezhda;
- Hegmane, Alinta;
- Trapencieris, Pēteris;
- Eglītis, Jānis;
- Linē, Aija
Publication type:
Article
A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA).
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 309, doi. 10.1007/s00280-014-2638-y
By:
- Kang, Yoon-Koo;
- Ryoo, Baek-Yeol;
- Yoon, Shinkyo;
- Shen, Lin;
- Lee, Jooyun;
- Wei, Chenlu;
- Zhou, Yu;
- Ryu, Min-Hee
Publication type:
Article
Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 247, doi. 10.1007/s00280-014-2640-4
By:
- Park, Ji;
- Lee, Jae-Lyun
Publication type:
Article
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in 'suboptimal' patients with advanced gastric cancer (AGC). TTD 08-02.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 319, doi. 10.1007/s00280-014-2641-3
By:
- Rivera, F.;
- Massutí, B.;
- Salcedo, M.;
- Sastre, J.;
- Martínez Galán, J.;
- Valladares-Ayerbes, M.;
- Serrano, R.;
- Paredes, Mª.;
- Manzano, J.;
- Galán, M.;
- Alsina, M.;
- Yuste Izquierdo, A.;
- López, C.;
- Díaz-Rubio, E.;
- Conde, V.;
- Reboredo, M.;
- Cano, Mª.;
- Pachón, V.;
- Aranda, E.
Publication type:
Article
Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 281, doi. 10.1007/s00280-014-2643-1
By:
- Clemens, Jannick;
- Seckinger, Anja;
- Hose, Dirk;
- Theile, Dirk;
- Longo, Magdalena;
- Haefeli, Walter;
- Burhenne, Jürgen;
- Weiss, Johanna
Publication type:
Article
Phase II study evaluating efficacy and safety of everolimus with letrozole for management of advanced (unresectable or metastatic) non-small cell lung cancer after failure of platinum-based treatment: a preliminary analysis of toxicity.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 325, doi. 10.1007/s00280-014-2644-0
By:
- Singhal, Nimit;
- Vatandoust, Sina;
- Brown, Michael
Publication type:
Article
Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 301, doi. 10.1007/s00280-014-2646-y
By:
- Gu, Xi;
- Zhang, Yang;
- Chen, Long;
- Guo, Jiao;
- Zhang, Wen-Hai
Publication type:
Article
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 343, doi. 10.1007/s00280-014-2647-x
By:
- Uronis, Hope;
- Jia, Jingquan;
- Bendell, Johanna;
- Howard, Leigh;
- Ready, Neal;
- Lee, Paula;
- Starr, Mark;
- Dellinger, Andrew;
- Pang, Herbert;
- Nixon, Andrew;
- Hurwitz, Herbert
Publication type:
Article
A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 293, doi. 10.1007/s00280-014-2648-9
By:
- Kanai, Masashi;
- Hatano, Etsuro;
- Kobayashi, Shogo;
- Fujiwara, Yutaka;
- Marubashi, Shigeru;
- Miyamoto, Atsushi;
- Shiomi, Hisanori;
- Kubo, Shoji;
- Ikuta, Shinichi;
- Yanagimoto, Hiroaki;
- Terajima, Hiroaki;
- Ikoma, Hisashi;
- Sakai, Daisuke;
- Kodama, Yuzo;
- Seo, Satoru;
- Morita, Satoshi;
- Ajiki, Tetsuo;
- Nagano, Hiroaki;
- Ioka, Tatsuya
Publication type:
Article
Pharmacokinetic/pharmacodynamic-based decision making in the development of MK-0888, a VEGFR-2/FLT-3 kinase inhibitor.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 333, doi. 10.1007/s00280-014-2649-8
By:
- Iwamoto, Marian;
- Friedman, Evan;
- Sepp-Lorenzino, Laura;
- Talaty, Jennifer;
- Agrawal, Nancy;
- Wagner, John
Publication type:
Article
Novel FTS-diamine/cinnamic acid hybrids inhibit tumor cell proliferation and migration and promote apoptosis via blocking Ras-related signaling in vitro.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 381, doi. 10.1007/s00280-014-2650-2
By:
- Ling, Yong;
- Zhao, Xinmei;
- Li, Xianghua;
- Wang, Xuemin;
- Yang, Yang;
- Wang, Zhiqiang;
- Wang, Xinyang;
- Zhang, Jie;
- Zhang, Yihua
Publication type:
Article
Oxymatrine targets EGFR and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 353, doi. 10.1007/s00280-014-2651-1
By:
- Guo, Bingyu;
- Zhang, Tingting;
- Su, Jingyuan;
- Wang, Kaiwen;
- Li, Xiaoming
Publication type:
Article
Onartuzumab with or without bevacizumab in combination with weekly paclitaxel does not prolong QTc or adversely affect other ECG parameters in patients with locally recurrent or metastatic triple-negative breast cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 401, doi. 10.1007/s00280-014-2652-0
By:
- Borin, Marie;
- Chen, Meng;
- Mocci, Simonetta;
- Rubets, Igor;
- Chittenden, Jason;
- Aldairy, Wassim;
- Stroh, Mark
Publication type:
Article
Novel in silico-designed estradiol analogues are cytotoxic to a multidrug-resistant cell line at nanomolar concentrations.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 431, doi. 10.1007/s00280-014-2653-z
By:
- Theron, Anne;
- Prudent, Renaud;
- Nolte, Elsie;
- Bout, Iman;
- Punchoo, Rivak;
- Marais, Sumari;
- du Toit, Peet;
- Hlophe, Yvette;
- Papendorp, Dirk;
- Lafanechère, Laurence;
- Joubert, Annie
Publication type:
Article
A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 373, doi. 10.1007/s00280-014-2654-y
By:
- Suzuki, Kazuhiro;
- Ozono, Seiichiro;
- Yamaguchi, Akito;
- Koike, Hidekazu;
- Matsui, Hiroshi;
- Nagata, Masao;
- Takubo, Takatoshi;
- Miyashita, Kana;
- Matsushima, Takafumi;
- Akaza, Hideyuki
Publication type:
Article
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 365, doi. 10.1007/s00280-014-2655-x
By:
- Hamberg, P.;
- Mathijssen, R.;
- Bruijn, P.;
- Leonowens, C.;
- Biessen, D.;
- Eskens, F.;
- Sleijfer, S.;
- Verweij, J.;
- Jonge, M.
Publication type:
Article
Prevalence and clinical significance of potential drug-drug interaction in hematopoietic stem cell transplantation.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 393, doi. 10.1007/s00280-014-2657-8
By:
- Trevisan, Danilo;
- Silva, Juliana;
- Oliveira, Henrique;
- Secoli, Silvia;
- Lima, Maria
Publication type:
Article
CEACAM1 and hollow spheroid formation modulate the chemosensitivity of colorectal cancer to 5-fluorouracil.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 421, doi. 10.1007/s00280-014-2662-y
By:
- Yamamoto, Naoyuki;
- Yokoyama, Shozo;
- Ieda, Junji;
- Mitani, Yasuyuki;
- Yamaguchi, Shunsuke;
- Takifuji, Katsunari;
- Hotta, Tsukasa;
- Matsuda, Kenji;
- Watanabe, Takashi;
- Shively, John;
- Yamaue, Hiroki
Publication type:
Article
Cks1 proteasomal degradation is induced by inhibiting Hsp90-mediated chaperoning in cancer cells.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 411, doi. 10.1007/s00280-014-2666-7
By:
- Khattar, Vinayak;
- Fried, Joshua;
- Xu, Bo;
- Thottassery, Jaideep
Publication type:
Article
Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 221, doi. 10.1007/s00280-014-2581-y
By:
- Garces, Álvaro;
- Dias, Mariane;
- Paulino, Eduardo;
- Ferreira, Carlos;
- Melo, Andréia
Publication type:
Article